← FDA Drug Approvals (Drugs@FDA)
BRIMONIDINE TARTRATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC · Approved 2023-03-29
Drug application
- FDA Application #
ANDA215225- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- BRIMONIDINE TARTRATE
- Generic name
- BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION, 0.15%
- Active ingredients
- BRIMONIDINE TARTRATE
- Dosage form
- SOLUTION/DROPS
- Route
- OPHTHALMIC
- Marketing status
- Prescription
- Sponsor
- ALEMBIC
- Manufacturer
- Alembic Pharmaceuticals Limited
- First approval
- 2023-03-29
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown